North America Antimicrobial Resistance Market (2025-2031) | Forecast, Strategic Insights, Restraints, Competition, Trends, Segmentation, Pricing Analysis, Demand, Industry, Growth, Investment Trends, Drivers, Analysis, Segments, Consumer Insights, Revenue, Strategy, Opportunities, Value, Size, Share, Challenges, Companies, Supply, Competitive, Outlook

Market Forecast by Countries (United States (US), Canada, Rest of North America), By Indication (Complicated Urinary Tract Infections (cUTI), Blood stream infections, Acute bacterial skin and skin structure infections (ABSSSI), Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), Community acquired pneumonia (CAP), Others), By Drug Class (Combination therapies, Tetracyclines, Cephalosporins, Glycopeptides and Lipoglycopeptides, Oxazolidinones, Others), By Mechanism of Action (Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, Others), By Pathogen (Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus Spp, Escherichia coli, Others) And Competitive Landscape
Product Code: ETC13236491 Publication Date: Apr 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 150 No. of Figures: 55 No. of Tables: 32

Key Highlights of the Report:

  • North America Antimicrobial Resistance Market Outlook
  • Market Size of North America Antimicrobial Resistance Market, 2024
  • Forecast of North America Antimicrobial Resistance Market, 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Revenues & Volume for the Period 2021 - 2031
  • North America Antimicrobial Resistance Market Trend Evolution
  • North America Antimicrobial Resistance Market Drivers and Challenges
  • North America Antimicrobial Resistance Price Trends
  • North America Antimicrobial Resistance Porter's Five Forces
  • North America Antimicrobial Resistance Industry Life Cycle
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Indication for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Complicated Urinary Tract Infections (cUTI) for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Blood stream infections for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Acute bacterial skin and skin structure infections (ABSSSI) for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP) for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Community acquired pneumonia (CAP) for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Indication for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Complicated Urinary Tract Infections (cUTI) for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Blood stream infections for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Acute bacterial skin and skin structure infections (ABSSSI) for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP) for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Community acquired pneumonia (CAP) for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Indication for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Complicated Urinary Tract Infections (cUTI) for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Blood stream infections for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Acute bacterial skin and skin structure infections (ABSSSI) for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP) for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Community acquired pneumonia (CAP) for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Indication for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Complicated Urinary Tract Infections (cUTI) for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Blood stream infections for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Acute bacterial skin and skin structure infections (ABSSSI) for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP) for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Community acquired pneumonia (CAP) for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Drug Class for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Combination therapies for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Tetracyclines for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Cephalosporins for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Glycopeptides and Lipoglycopeptides for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Oxazolidinones for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Drug Class for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Combination therapies for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Tetracyclines for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Cephalosporins for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Glycopeptides and Lipoglycopeptides for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Oxazolidinones for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Drug Class for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Combination therapies for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Tetracyclines for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Cephalosporins for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Glycopeptides and Lipoglycopeptides for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Oxazolidinones for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Drug Class for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Combination therapies for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Tetracyclines for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Cephalosporins for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Glycopeptides and Lipoglycopeptides for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Oxazolidinones for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Mechanism of Action for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Protein Synthesis Inhibitors for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Cell Wall Synthesis Inhibitors for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Mechanism of Action for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Protein Synthesis Inhibitors for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Cell Wall Synthesis Inhibitors for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Mechanism of Action for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Protein Synthesis Inhibitors for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Cell Wall Synthesis Inhibitors for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Mechanism of Action for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Protein Synthesis Inhibitors for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Cell Wall Synthesis Inhibitors for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Pathogen for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Klebsiella pneumoniae for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Pseudomonas aeruginosa for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Staphylococcus aureus for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Enterococcus Spp for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Escherichia coli for the Period 2021 - 2031
  • Historical Data and Forecast of North America Antimicrobial Resistance Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Pathogen for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Klebsiella pneumoniae for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Pseudomonas aeruginosa for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Staphylococcus aureus for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Enterococcus Spp for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Escherichia coli for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Antimicrobial Resistance Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Pathogen for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Klebsiella pneumoniae for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Pseudomonas aeruginosa for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Staphylococcus aureus for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Enterococcus Spp for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Escherichia coli for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Antimicrobial Resistance Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Pathogen for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Klebsiella pneumoniae for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Pseudomonas aeruginosa for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Staphylococcus aureus for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Enterococcus Spp for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Escherichia coli for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Antimicrobial Resistance Market Revenues & Volume By Others for the Period 2021 - 2031
  • North America Antimicrobial Resistance Market - Key Performance Indicators
  • North America Antimicrobial Resistance Market - Import Export Trade Statistics
  • North America Antimicrobial Resistance Market - Opportunity Assessment By Countries
  • North America Antimicrobial Resistance Market - Opportunity Assessment By Indication
  • North America Antimicrobial Resistance Market - Opportunity Assessment By Drug Class
  • North America Antimicrobial Resistance Market - Opportunity Assessment By Mechanism of Action
  • North America Antimicrobial Resistance Market - Opportunity Assessment By Pathogen
  • North America Antimicrobial Resistance Market - Top Companies Market Share
  • North America Antimicrobial Resistance Market - Top Companies Profiles
  • North America Antimicrobial Resistance Market - Comparison of Players in Technical and Operating Parameters
  • North America Antimicrobial Resistance Market - Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the North America Antimicrobial Resistance Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the North America Antimicrobial Resistance Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

North America Antimicrobial Resistance Market

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 North America Antimicrobial Resistance Market Overview

3.1 North America Regional Macro Economic Indicators

3.2 North America Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F

3.3 North America Antimicrobial Resistance Market - Industry Life Cycle

3.4 North America Antimicrobial Resistance Market - Porter's Five Forces

3.5 North America Antimicrobial Resistance Market Revenues & Volume Share, By Countries, 2021 & 2031F

3.6 North America Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.7 North America Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.8 North America Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F

3.9 North America Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F

4 North America Antimicrobial Resistance Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 North America Antimicrobial Resistance Market Trends

6 North America Antimicrobial Resistance Market, 2021 - 2031

6.1 North America Antimicrobial Resistance Market, Revenues & Volume, By Indication, 2021 - 2031

6.1.1 Overview & Analysis

6.1.2 North America Antimicrobial Resistance Market, Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021 - 2031

6.1.3 North America Antimicrobial Resistance Market, Revenues & Volume, By Blood stream infections, 2021 - 2031

6.1.4 North America Antimicrobial Resistance Market, Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021 - 2031

6.1.5 North America Antimicrobial Resistance Market, Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021 - 2031

6.1.6 North America Antimicrobial Resistance Market, Revenues & Volume, By Community acquired pneumonia (CAP), 2021 - 2031

6.1.7 North America Antimicrobial Resistance Market, Revenues & Volume, By Others, 2021 - 2031

6.2 North America Antimicrobial Resistance Market, Revenues & Volume, By Drug Class, 2021 - 2031

6.2.1 Overview & Analysis

6.2.2 North America Antimicrobial Resistance Market, Revenues & Volume, By Combination therapies, 2021 - 2031

6.2.3 North America Antimicrobial Resistance Market, Revenues & Volume, By Tetracyclines, 2021 - 2031

6.2.4 North America Antimicrobial Resistance Market, Revenues & Volume, By Cephalosporins, 2021 - 2031

6.2.5 North America Antimicrobial Resistance Market, Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021 - 2031

6.2.6 North America Antimicrobial Resistance Market, Revenues & Volume, By Oxazolidinones, 2021 - 2031

6.2.7 North America Antimicrobial Resistance Market, Revenues & Volume, By Others, 2021 - 2031

6.3 North America Antimicrobial Resistance Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031

6.3.1 Overview & Analysis

6.3.2 North America Antimicrobial Resistance Market, Revenues & Volume, By Protein Synthesis Inhibitors, 2021 - 2031

6.3.3 North America Antimicrobial Resistance Market, Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021 - 2031

6.3.4 North America Antimicrobial Resistance Market, Revenues & Volume, By Others, 2021 - 2031

6.4 North America Antimicrobial Resistance Market, Revenues & Volume, By Pathogen, 2021 - 2031

6.4.2 North America Antimicrobial Resistance Market, Revenues & Volume, By Klebsiella pneumoniae, 2021 - 2031

6.4.3 North America Antimicrobial Resistance Market, Revenues & Volume, By Pseudomonas aeruginosa, 2021 - 2031

6.4.4 North America Antimicrobial Resistance Market, Revenues & Volume, By Staphylococcus aureus, 2021 - 2031

6.4.5 North America Antimicrobial Resistance Market, Revenues & Volume, By Enterococcus Spp, 2021 - 2031

6.4.6 North America Antimicrobial Resistance Market, Revenues & Volume, By Escherichia coli, 2021 - 2031

6.4.7 North America Antimicrobial Resistance Market, Revenues & Volume, By Others, 2021 - 2031

7 North America Antimicrobial Resistance Market, By Countries, 2021 - 2031

7.1 Overview & Analysis

7.2 North America Antimicrobial Resistance Market, Revenues & Volume, By Indication, 2021 - 2031

7.2.1 United States (US) Antimicrobial Resistance Market, Revenues & Volume, By Indication, 2021 - 2031

7.2.2 Canada Antimicrobial Resistance Market, Revenues & Volume, By Indication, 2021 - 2031

7.2.3 Rest of North America Antimicrobial Resistance Market, Revenues & Volume, By Indication, 2021 - 2031

7.3 North America Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

7.3.1 United States (US) Antimicrobial Resistance Market, Revenues & Volume, By Drug Class, 2021 - 2031

7.3.2 Canada Antimicrobial Resistance Market, Revenues & Volume, By Drug Class, 2021 - 2031

7.3.3 Rest of North America Antimicrobial Resistance Market, Revenues & Volume, By Drug Class, 2021 - 2031

7.4 North America Antimicrobial Resistance Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031

7.4.1 United States (US) Antimicrobial Resistance Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031

7.4.2 Canada Antimicrobial Resistance Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031

7.4.3 Rest of North America Antimicrobial Resistance Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031

7.5 North America Antimicrobial Resistance Market, Revenues & Volume, By Pathogen, 2021 - 2031

7.5.1 United States (US) Antimicrobial Resistance Market, Revenues & Volume, By Pathogen, 2021 - 2031

7.5.2 Canada Antimicrobial Resistance Market, Revenues & Volume, By Pathogen, 2021 - 2031

7.5.3 Rest of North America Antimicrobial Resistance Market, Revenues & Volume, By Pathogen, 2021 - 2031

8 North America Antimicrobial Resistance Market Key Performance Indicators

9 North America Antimicrobial Resistance Market - Export/Import By Countries Assessment

10 North America Antimicrobial Resistance Market - Opportunity Assessment

10.1 North America Antimicrobial Resistance Market Opportunity Assessment, By Countries, 2021 & 2031F

10.2 North America Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F

10.3 North America Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F

10.4 North America Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F

10.5 North America Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F

11 North America Antimicrobial Resistance Market - Competitive Landscape

11.1 North America Antimicrobial Resistance Market Revenue Share, By Companies, 2022

11.2 North America Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters

12 Top 10 Company Profiles

13 Recommendations

14 Disclaimer

Pricing
  • Single User License
    $ 4,560
  • Department License
    $ 5,055
  • Site License
    $ 5,595
  • Global License
    $ 6,000
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All